Clinical Innovations, Inc.

Costa Mesa, California 92647

0 studies enrolling now · 16 studies all time

What they study most

Attention Deficit Hyperactivity Disorder, Autistic Disorder, Behavioral Symptoms, Bipolar Depression, Bipolar Disorder, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Schizophrenia, Diabetes Mellitus, Type 2, Insomnia, Irritability Associated With Autistic Disorder, Major Depressive Disorder, Schizoaffective Disorder

Studies at this site

• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia — Completed
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus — Completed
• An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis — Completed
• Bio-equivalence Study Between SAPHRIS and Asenapine — Completed
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
• Add-on to Thiazolidinedione (TZD) Failures — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia — Completed
• Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression — Completed
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed